Texas lawmakers are considering major changes to the state’s medical marijuana program while cracking down on hemp-derived THC products—sparking division among patients, veterans, and cannabis advocates.
Legislators are currently considering legislation that would significantly broaden the Texas Compassionate Use Program (TCUP), alongside a proposal to prohibit all hemp-derived THC products, which encompasses widely used delta-8 and delta-9 gummies and oils.
The decision has created a significant rift within the patient community, especially among veterans who are exploring alternatives to opioids and traditional pharmaceuticals.
Jamal Pack, a former football player at LSU, has expressed that Texas’ medical marijuana program may provide relief for the pain and PTSD he has experienced since his time in the sport.
However, the expenses and bureaucratic hurdles compel him to depend on over-the-counter delta-8 products, which he claims are more affordable and readily available. The contrast serves as a focal point in an escalating policy debate unfolding in Texas.
David Bass, the director of Texas Veterans for Medical Marijuana, has expressed his support for implementing stricter regulations. “Cannabis is not aspirin,” he stated.
Experts describe it as a potent psychoactive substance. Prescription is essential; it should not be purchased casually. Concerns have been raised by individuals such as Mitch Fuller from the Veterans of Foreign Wars, who argue that prohibiting hemp products could lead to reduced accessibility of cannabis for a significant number of people. Fuller expressed concerns, stating, “We don’t want to get caught in the cannabis civil war.” “Veterans require access to all available options.”
Since its inception in 2015, TCUP has served approximately 10,000 patients. Advocates point to stringent regulations, a scarcity of providers, and escalating expenses. At present, the state is served by just two licensed suppliers, both of which are located in Austin.
A third establishment has recently reopened in the rural area of Schulenberg. The legalization of hemp in 2019 has led to the emergence of an estimated $8 billion market for hemp-derived THC, a development that has raised concerns among Lt. Gov. Dan Patrick and other lawmakers who argue that such growth was not part of the original intent.
Recent proposals aim to expand the eligibility criteria for TCUP to encompass chronic pain management involving opioids. Additionally, these proposals seek to introduce new vendors and delivery methods, while also allocating funds for increased regional storage sites to facilitate distribution.
Advocates express optimism that the proposed changes may align the program more closely with patient needs. However, they caution that without addressing costs and access, a significant number of individuals may continue to rely on the hemp market.
